Ortin Global (BOM:539287) Cyclically Adjusted Revenue per Share: ₹89.51 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539287 Ortin Global Ltd BOM:539287
43 GF Score
Price ₹15.19
GF Value ₹1.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ortin Global Cyclically Adjusted Revenue per Share?

Ortin Global BOM:539287 +1.95% 43 Cyclically Adjusted Revenue per Share is ₹89.51 as of Jun. 2026. GuruFocus rates BOM:539287 with a GF Score™ of 43/100 and a GF Value™ of ₹1.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ortin Global's adjusted revenue per share for the three months ended in Jun. 2026 was ₹0.014. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹89.51 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ortin Global's average Cyclically Adjusted Revenue Growth Rate was -5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -5.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ortin Global was -4.90% per year. The lowest was -6.10% per year. And the median was -5.20% per year.

As of today (2026-09-01), Ortin Global's current stock price is ₹15.19. Ortin Global's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹89.51. Ortin Global's Cyclically Adjusted PS Ratio of today is 0.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ortin Global was 0.39. The lowest was 0.10. And the median was 0.20.


Ortin Global  (BOM:539287) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ortin Global's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=15.19/89.51
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ortin Global was 0.39. The lowest was 0.10. And the median was 0.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ortin Global Cyclically Adjusted Revenue per Share Related Terms


Ortin Global Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ortin Global's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortin Global Cyclically Adjusted Revenue per Share Chart

Ortin Global Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.39 105.76 98.63 95.89 90.21

Ortin Global Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.83 94.98 93.03 90.21 89.51

BOM:539287 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Global Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ortin Global's Cyclically Adjusted PS Ratio falls into.


BOM:539287
43GF Score
Ortin Global Ltd BOM:539287
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ortin Global Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ortin Global's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.014/167.3573*167.3573
=0.014

Current CPI (Jun. 2026) = 167.3573.

Ortin Global Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 10.772 105.961 17.014
201612 12.845 105.196 20.435
201703 24.754 105.196 39.381
201706 13.471 107.109 21.048
201709 13.638 109.021 20.936
201712 21.889 109.404 33.484
201803 51.017 109.786 77.770
201806 40.830 111.317 61.385
201809 53.946 115.142 78.410
201812 57.468 115.142 83.529
201903 53.861 118.202 76.259
201906 48.851 120.880 67.634
201909 37.074 123.175 50.372
201912 66.819 126.235 88.586
202003 85.389 124.705 114.594
202006 94.470 127.000 124.490
202009 93.852 130.118 120.712
202012 63.392 130.889 81.054
202103 -241.169 131.771 -306.301
202106 2.396 134.084 2.991
202109 2.984 135.847 3.676
202112 2.025 138.161 2.453
202203 2.508 138.822 3.024
202206 3.193 142.347 3.754
202209 0.973 144.661 1.126
202212 1.421 145.763 1.632
202303 1.904 146.865 2.170
202306 1.916 150.280 2.134
202309 0.320 151.492 0.354
202312 0.167 152.924 0.183
202403 0.178 153.035 0.195
202406 0.263 155.789 0.283
202409 0.067 157.882 0.071
202412 0.041 158.323 0.043
202503 0.055 157.552 0.058
202506 0.050 159.755 0.052
202509 0.017 162.289 0.018
202512 0.016 163.281 0.016
202603 0.037 164.272 0.038
202606 0.014 167.357 0.014

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹89.51 mean?
Ortin Global (BOM:539287) has a Cyclically Adjusted Revenue per Share of ₹89.51 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ortin Global and its competitors.
Is Ortin Global's Cyclically Adjusted Revenue per Share too high?
Ortin Global's current Cyclically Adjusted Revenue per Share is ₹89.51. Overall, Ortin Global has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ortin Global's Cyclically Adjusted Revenue per Share compare to ZTS?
Ortin Global's Cyclically Adjusted Revenue per Share of ₹89.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ortin Global and its competitors. Ortin Global's current Cyclically Adjusted Revenue per Share is ₹89.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortin Global stock overvalued right now?
Based on GuruFocus' analysis, Ortin Global (BOM:539287) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.99, compared to a current price of ₹15.19 — trading 663.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹89.51. Ortin Global's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ortin Global (BOM:539287), the current Cyclically Adjusted Revenue per Share is ₹89.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ortin Global (BOM:539287) Overvalued in 2026?

Based on GuruFocus' analysis, Ortin Global stock appears to be overvalued. The current stock price of ₹15.19 is trading 663.3% above its estimated GF Value™ of ₹1.99. GuruFocus considers Ortin Global to be Significantly Overvalued.

Key valuation signals for BOM:539287:

  • Cyclically Adjusted Revenue per Share: ₹89.51
  • GF Value™: ₹1.99 vs. price of ₹15.19 (663.3% above fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the BOM:539287 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ortin Global Business Description

Other Exchanges ORTINGLOBE:India
Address G Block, Plot No. C-66, 9th Floor, 915, One BKC, Bandra Kurla Complex, Bandra East, Mumbai, MH, IND, 400051
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helminthics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zidovudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. Additionally, the company is also involved in the real estate business.
43GF Score

Get the complete analysis for BOM:539287

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.19
Price
₹1.99
GF Value